XML 34 R66.htm IDEA: XBRL DOCUMENT v3.20.1
17. Share Based Payments - Narrative (Details)
$ in Thousands
12 Months Ended
Apr. 20, 2018
USD ($)
Y
tranche
$ / shares
shares
Apr. 20, 2018
EUR (€)
Y
tranche
shares
Dec. 31, 2019
EquityInstruments
USD ($)
$ / shares
Dec. 31, 2019
EUR (€)
EquityInstruments
Y
shares
Dec. 31, 2018
EquityInstruments
$ / shares
Dec. 31, 2018
EUR (€)
EquityInstruments
Y
shares
Dec. 31, 2017
EUR (€)
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Vesting period (in years) 3 years 3 years          
Number of options issued | €   240,000          
Number of tranches | tranche 3 3          
Trading days 15 days 15 days          
Share price at grant date     $ 1.44   $ 1.91    
Grant date fair value $ 164 € 133,000          
Expected life | Y 2 2   5.9   5.9  
Options exercisable | $     0        
Share-based expense | €       € 2,469,000   € 2,035,000 € 1,943,000
Number of options issued | shares 240,000 240,000          
Tranche I              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Share price at grant date $ 6.15            
Tranche II              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Share price at grant date 8.20            
Tranche III              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Share price at grant date $ 10.25            
Research and Development              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Share-based expense | €       904,000   852,000 522,000
General and Administrative              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Share-based expense | €       € 1,565,000   € 1,183,000 € 1,421,000
ESOP 2014              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Vesting period (in years)       3 years      
Awards granted | EquityInstruments       1,736,803   2,332,296  
Awards cancelled or forfeited | EquityInstruments       357,879   424,688  
Awards outstanding | EquityInstruments     7,307,567   5,948,438    
Awards exercised | shares       19,795   40,038  
Average exercise price of awards exercised     $ 1.54   $ 1.98    
Awards vested | EquityInstruments       4,773,840   2,814,547  
Annual forfeiture rate       4.00%   4.00%  
Weighted average remaining contractual life       8 years 10 months 24 days   9 years 3 months 18 days  
Exercise period       10 years      
ESOP 2014 | Minimum              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Exercise price     1.30   1.30    
ESOP 2014 | Maximum              
Disclosure of terms and conditions of share-based payment arrangement [line items]              
Exercise price     $ 13.47   $ 13.47